News

Regulatory affairsRegulatory Round-up - March 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityPress release: CGT Catapult announces vector production agreement with AdaptimmunePress release: CGT Catapult announces vector production agreement with AdaptimmuneCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessRegulatory news - December 2017Regulatory news - December 2017December newsletterDecember newsletterGrowth in UK cell and gene therapy industry continues for fifth year runningGrowth in UK cell and gene therapy industry continues for fifth year runningPress release: CGT Catapult to collaborate with Oxford MEStar and AK (Suzhou) Biomedical as part of Jiangsu-UK industrial challenge programmePress release: CGT Catapult to collaborate with Oxford MEStar and AK (Suzhou) Biomedical as part of Jiangsu-UK industrial challenge programmeRegulatory news - November 2017Regulatory news - November 2017November newsletterNovember newsletterSeptember newsletterSeptember newsletterAugust newsletterAugust newsletter